Get started
Author

Ferit Aslan

Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
2023 · Cengiz Karacin, Berna Oksuzoglu, et al. · BMC Cancer · 24
PDF
Application of Disposable Biosensor for Nivolumab–DNA Interaction Using Pencil Graphite Electrode
2023 · M. Aslan, F. Aydın, et al. · Russian Journal of Electrochemistry · 14
Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study
2024 · Hasan Cagri Yildirim, Caner Kapar, et al. · Journal of Chemotherapy · 10
The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study
2024 · Hasan Çağrı Yıldırım, Yasin Kutlu, et al. · International Journal of Clinical Oncology · 10
Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel
2025 · Hakan Taban, Mustafa Erman, et al. · Medicina · 7
PDF
Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG)
2024 · Arif Akyildiz, Deniz Can Guven, et al. · European Archives of Oto-Rhino-Laryngology · 6
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
2023 · Cengiz Karacin, Berna Oksuzoglu, et al. · BMC Cancer · 5
PDF
The role of inflammatory parameters in predicting disease recurrence in patients with stage IIA colon cancer with no high-risk features
2021 · Erkan Erdur, Ozgen Ahmet Yildirim, et al. · Postgraduate Medicine · 5
Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group
2025 · Salih Tunbekici, Gokhan Sahin, et al. · International Journal of Cancer · 3
Renal Cell Carcinoma in Pregnancy With Breast Metastasis: A Case Report and Literature Review
2025 · Ferit Aslan, Burcu Erkılıç, et al. · Cureus · 3
PDF
Bevacizumab versus aflibercept with FOLFIRI after FOLFOX and bevacizumab in RAS mutant metastatic colon cancer a Turkish oncology group study
2024 · Serhat Sekmek, Sema Nur Ozsan Çelebi, et al. · Scientific Reports · 3
Gallbladder Polyp and Cancer Evaluation After Cholecystectomy: A Retrospective Observational Study
2022 · Ahmet Alyanak, Ferit Aslan · Cureus · 3
PDF
Glioblastoma Multiforme With CDKN2A, Loss of PTEN and EGFR Amplification, and Diffuse Distant Organ Metastasis Treated With Six Lines of Therapy: A Case Report and Literature Review
2022 · Ferit Aslan, Elif Günaydın, et al. · Cureus · 3
PDF
First line modified Folfirinox versus gemcitabine for advanced pancreatic cancer: A single institution retrospective experience
2019 · Emrah Eraslan, Fatih Yildiz, et al. · Journal of Oncological Sciences · 3
PDF
Gastric Medullary Carcinoma: A Rare Case Report
2016 · Ferit Aslan, Fisun Ardıç Yükrük, et al. · Case Reports in Oncological Medicine · 3
PDF
Cystic Hygroma with Multiple Benign Bone Lymphangiomas in an Adult Patient: A Rare Entity in the Differential Diagnosis of Multiple Osseous Lesions in Oncology Practice
2021 · Ferit Aslan, İnanç Güvenç, et al. · Current Medical Imaging Formerly Current Medical Imaging Reviews · 2
Merkel cell carcinoma in Turkey: A multicentric study
2020 · Fatih Yildiz, Umut Demirci, et al. · Journal of Cancer Research and Therapeutics · 2
Is intensity-modulated radiotherapy superior to conventional techniques to prevent late ear complications of nasopharyngeal cancer?
2019 · Ayca Ant, Ömer Yazici, et al. · European Archives of Oto-Rhino-Laryngology · 2
Clinical Significance of Achieving No Evidence of Disease in HER2-Positive Metastatic Breast Cancer: A Multicenter Study by Turkish Oncology Group (TOG)
2026 · Bengü Dursun, Şendağ Yaslıkaya, et al. · Cancers · 1
PDF
Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (TOG)
2026 · Sercan On, Selin Cebeci, et al. · Cancers · 1
PDF
Early‐Onset Posterior Reversible Encephalopathy Syndrome at Reduced‐Dose Sunitinib in Metastatic Papillary Renal Cell Carcinoma: A Case Report
2026 · Ferit Aslan, Burcu Erkılıç, et al. · Case Reports in Medicine · 1
Durvalumab-Based First-Line Chemoimmunotherapy in Advanced Biliary Tract Cancer: Real-World Outcomes and Prognostic Factors—A Turkish Oncology Group Study
2025 · Safa Can Efil, Fatih Kus, et al. · Cancers · 1
PDF
Real-World Experience with Non-Metastatic Male Breast Cancer: A 222-Patient Multicenter Study from the Turkish Oncology Group (TOG)
2025 · Ülkü Yalçıntaş Arslan, Ferit Aslan, et al. · Cancers · 1
PDF
Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment
2024 · Murat Bardakci, Hilal Karakas, et al. · Scientific Reports · 1
Evaluation of a Year During the COVID-19 Pandemic in a Private Healthcare Facility: Retrospective Cross-Sectional Study
2022 · Burçin Budakoğlu, Tonguç Sugüneş, et al. · Cureus · 1
PDF
Works count: 80
Citation count: 123
H-index: 6
I10-index: 4
Year
Topic
Type